A Giant Variant of Acquired Reactive Perforating Collagenosis Successfully Treated with Nemolizumab.

Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab Kiyoko Yamada, Corresponding Author Kiyoko Yamada [email protected] orcid.org/0009-0006-8314-7260 Department of Dermatology, Kagoshima City Hospital, Kagoshima, Japan Correspondence Kiyoko Yamada, Department of Dermatology, Kagoshima City Hospital 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Email: [email protected]Search for more papers by this authorAtsunori Baba, Atsunori Baba orcid.org/0000-0002-6981-3451 Department of Dermatology, Kagoshima City Hospital, Kagoshima, JapanSearch for more papers by this authorTakuro Kanekura, Takuro Kanekura orcid.org/0000-0003-3904-5954 Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, JapanSearch for more papers by this author Kiyoko Yamada, Corresponding Author Kiyoko Yamada [email protected] orcid.org/0009-0006-8314-7260 Department of Dermatology, Kagoshima City Hospital, Kagoshima, Japan Correspondence Kiyoko Yamada, Department of Dermatology, Kagoshima City Hospital 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Email: [email protected]Search for more papers by this authorAtsunori Baba, Atsunori Baba orcid.org/0000-0002-6981-3451 Department of Dermatology, Kagoshima City Hospital, Kagoshima, JapanSearch for more papers by this authorTakuro Kanekura, Takuro Kanekura orcid.org/0000-0003-3904-5954 Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, JapanSearch for more papers by this author First published: 15 February 2024 https://doi.org/10.1111/jdv.19864Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1García-Malinis AJ, Del Valle Sánchez E, Sánchez-Salas MP, Del Prado E, Coscojuela C, Gilaberte Y. Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment. J Eur Acad Dermatol Venereol. 2017; 31(10): 1757–1763. 10.1111/jdv.14220 CASPubMedWeb of Science®Google Scholar 2Kusutani N, Arai S, Imanishi A, Maekawa N, Fukai K. A giant variant of acquired reactive perforating collagenosis. Int J Dermatol. 2022; 61(7): e250–e252. 10.1111/ijd.15797 PubMedWeb of Science®Google Scholar 3Saray Y, Seçkin D, Bilezikçi B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol. 2006; 20(6): 679–688. 10.1111/j.1468-3083.2006.01571.x CASPubMedWeb of Science®Google Scholar 4Kestner RI, Ständer S, Osada N, Ziegler D, Metze D. Acquired reactive perforating dermatosis is a variant of prurigo nodularis. Acta Derm Venereol. 2017; 97(2): 249–254. 10.2340/00015555-2492 PubMedWeb of Science®Google Scholar 5Kawamura M, Inoue M, Matsuyama K, Mizutani Y, Shu E, Miyazaki T, et al. Clinicopathological differences between acquired reactive perforating collagenosis and prurigo nodularis. J Clin Exp Dermatol Res. 2021; 12(8): 550. Google Scholar 6Hashimoto T, Kursewicz CD, Fayne RA, Nanda S, Shah SM, Nattkemper L, et al. Mechanisms of itch in stasis dermatitis: significant role of IL-31 from macrophages. J Invest Dermatol. 2020; 140(4): 850–859.e3. 10.1016/j.jid.2019.09.012 CASPubMedWeb of Science®Google Scholar 7Hashimoto T, Yokozeki H, Karasuyama H, Satoh T. IL-31–generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin. J Allergy Clin Immunol. 2023; 151(3): 737–746.e6. 10.1016/j.jaci.2022.11.009 CASPubMedGoogle Scholar 8Kawakami T, Ikeda T, Yokoyama K, Dong Y. μ-Opioid receptor overexpression in acquired reactive perforating collagenosis associated with IL-31. J Dermatol Sci. 2023; 110(2): 69–71. 10.1016/j.jdermsci.2023.04.003 CASPubMedGoogle Scholar 9Ohmori S, Sawada Y. Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab. Clin Exp Dermatol. 2023; 48(8): 929–941. 10.1093/ced/llad119 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation